Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer
| Image |  |
|---|---|
| Description | scientific article published on 20 April 2020 |
| Author/s |
author: George R Blumenschein |
| Publication date | April 20, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |